Paragonix Technologies Announces Launch of CONCERT-DCD Clinical Trial in Collaboration with UW Medicine to Maximize Heart Transplant Utilization

Prospective, multicenter trial will evaluate a novel preservation technique utilizing the Paragonix SherpaPak® for DCD (Donation after Circulatory Death) hearts